Arend Jan Gerard Jansen (A J G Jansen, A J Gerard Jansen)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 18

Top Venues

Blood advances

British journal of haematology

The New England journal of medicine

Research and practice in thrombosis and haemostasis

Sanquin Research

Sanquin Research (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Sanquin Research

Netherlands

Senior scientist

Sanquin Research

Netherlands

Senior scientist

King's College London

United Kingdom

Postdoc

Brigham and Women's Hospital Feb 01 2007 - Dec 31 2007

United States

Postdoc

Harvard Medical School

United States

Postdoc

Education History

Sanquin Research Sep 01 2000 - Jan 11 2007

Netherlands

PHD

VU University Amsterdam

Netherlands

MSC :: Clinical Epidemiology

Publications

David J Kuter, Jiří Mayer, Merlin Efraim, Lachezar H Bogdanov, Ross Ian Baker, Zane Kaplan, Mamta Garg, Marek Trněný, Philip Young-Ill Choi, Arend Jan Gerard Jansen, Vickie McDonald, Robert J Bird, Jaromir Gumulec, Milan Košťál, Terry Gernsheimer, Waleed Ghanima, Ahmed A Daak, Nichola Cooper
Long-term treatment with rilzabrutinib in patients with immune thrombocytopenia. Blood advances 8 (7) (2024)
David J Kuter, Jiří Mayer, Merlin Efraim, Lachezar H Bogdanov, Ross Ian Baker, Zane Kaplan, Mamta Garg, Marek Trněný, Philip Young-Ill Choi, Arend Jan Gerard Jansen, Vickie McDonald, Robert J Bird, Jaromir Gumulec, Milan Košťál, Terry Gernsheimer, Waleed Ghanima, Ahmed A Daak, Nichola Cooper
Long-term treatment with rilzabrutinib in patients with immune thrombocytopenia. Blood advances 8 (7) (2024)
David J Kuter, Jiri Mayer, Merlin Efraim, Lachezar H Bogdanov, Ross Ian Baker, Zane S Kaplan, Mamta Garg, Marek Trněný, Philip Young-Ill Choi, Arend Jan Gerard Jansen, Vickie McDonald, Robert J Bird, Jaromir Gumulec, Milan Košťál, Terry Gernsheimer, Waleed Ghanima, Ahmed Abd Almalik Daak, Nichola Cooper
Long-term treatment with rilzabrutinib in patients with immune thrombocytopenia. Blood advances (2024)
Frank E H P van Baarle, Emma K van de Weerdt, Walter J F M van der Velden, Roelof A Ruiterkamp, Pieter R Tuinman, Paula F Ypma, Walter M van den Bergh, Astrid M P Demandt, Emile D Kerver, Arend Jan Gerard Jansen, Peter E Westerweel, M Sesmu Arbous, Rogier M Determann, Walther N K A van Mook, Mirelle Koeman, Anja B U Mäkelburg, Krijn P van Lienden, Alexander P. J. Vlaar, Bart J Biemond
Predictors of the corrected count increment after platelet transfusion, a secondary analysis of the PACER randomized controlled trial. American journal of hematology (2023)
Frank E H P van Baarle, Emma K van de Weerdt, Walter J F M van der Velden, Roelof A Ruiterkamp, Pieter R Tuinman, Paula F Ypma, Walter M van den Bergh, Astrid M P Demandt, Emile D Kerver, Arend Jan Gerard Jansen, Peter E Westerweel, Sesmu M Arbous, Rogier M Determann, Walther N K A van Mook, Mirelle Koeman, Anja B U Mäkelburg, Krijn P van Lienden, Jan M Binnekade, Bart J Biemond, Alexander P. J. Vlaar
Platelet Transfusion before CVC Placement in Patients with Thrombocytopenia. The New England journal of medicine 388 (21) (2023)
Sara Stefani, Noora Buti, Alice C J Hart, Deena Paul, Naghma Rizvi, Vashti Ragoonanan, Camelia Vladescu, Richard Szydlo, Christine Ademokun, Arend Jan Gerard Jansen, Nichola Cooper
Safety and efficacy of SARS-CoV-2 vaccination in patients with immune thrombocytopenia: A two-centre review. British journal of haematology (2023)
Maurice Swinkels, Ferdows Atiq, Petra E Bürgisser, Iris van Moort, Karina Meijer, Jeroen Eikenboom, Karin Fijnvandraat, Karin P M van Galen, Joke de Meris, Saskia E M Schols, Johanna G van der Bom, Marjon H Cnossen, Jan Voorberg, Frank W G Leebeek, Ruben Bierings, Arend Jan Gerard Jansen, null null
Platelet degranulation and bleeding phenotype in a large cohort of Von Willebrand disease patients. British journal of haematology 197 (4) (2022)
Chantal Visser, Maurice Swinkels, Erik D van Werkhoven, F Nanne Croles, Heike S Noordzij-Nooteboom, Matthijs Eefting, Suzanne M Last-Koopmans, Cecile Idink, Peter E Westerweel, Bart Santbergen, Pieter A Jobse, Fazil Baboe, null null, Peter A W Te Boekhorst, Frank W G Leebeek, Mark-David Levin, Marieke J H A Kruip, Arend Jan Gerard Jansen
COVID-19 vaccination in patients with immune thrombocytopenia. Blood advances 6 (6) (2022)
Tessa Noordermeer, Roger E G Schutgens, Chantal Visser, Emma Rademaker, Moniek P M de Maat, Arend Jan Gerard Jansen, Maarten Limper, Olaf L Cremer, Marieke J H A Kruip, Henrik Endeman, Coen Maas, Bas de Laat, Rolf T Urbanus, null null
Lupus anticoagulant associates with thrombosis in patients with COVID-19 admitted to intensive care units: A retrospective cohort study. Research and practice in thrombosis and haemostasis 6 (6) (2022)
David J Kuter, Merlin Efraim, Jiri Mayer, Marek Trněný, Vickie McDonald, Robert Bird, Thomas Regenbogen, Mamta Garg, Zane Kaplan, Nikolay Tzvetkov, Philip Young-Ill Choi, Arend Jan Gerard Jansen, Milan Kostal, Ross Baker, Jaromir Gumulec, Eun-Ju Lee, Ilona Cunningham, Isaac Goncalves, Margaret Warner, Ralph Boccia, Terry Gernsheimer, Waleed Ghanima, Olga Bandman, Regan Burns, Ann Neale, Dolca Thomas, Puneet Arora, Beiyao Zheng, Nichola Cooper
Rilzabrutinib, an Oral BTK Inhibitor, in Immune Thrombocytopenia. The New England journal of medicine 386 (15) (2022)
Ana Bura, Maria Antonietta de Matteis, Markus Bender, Maurice Swinkels, Jurjen Versluis, Arend Jan Gerard Jansen, Antonija Jurak Begonja
Oculocerebrorenal syndrome of Lowe protein controls cytoskeletal reorganisation during human platelet spreading. British journal of haematology (2022)
Maurice Swinkels, Ferdows Atiq, Petra E Bürgisser, Johan A Slotman, Adriaan B Houtsmuller, Cecilia de Heus, Judith Klumperman, Frank W G Leebeek, Jan Voorberg, Arend Jan Gerard Jansen, Ruben Bierings
Quantitative 3D microscopy highlights altered von Willebrand factor α-granule storage in patients with von Willebrand disease with distinct pathogenic mechanisms. Research and practice in thrombosis and haemostasis 5 (6) (2021)
Ruben Van Dijck, Mandy N Lauw, Maurice Swinkels, Henk Russcher, Arend Jan Gerard Jansen
COVID-19-associated pseudothrombocytopenia. EJHaem (2021)
Eva K Kempers, Virgil A S H Dalm, Marie Josee E van Rijn, Annemarie G M G J Mulders, Frank W G Leebeek, Moniek P M de Maat, Arend Jan Gerard Jansen
Indication and outcome of lupus anticoagulant and antiphospholipid antibodies testing in routine clinical practice. Rheumatology advances in practice 5 (3) (2021)
Gienke Bomhof, Pim G N J Mutsaers, Frank W G Leebeek, Peter A W Te Boekhorst, Johannes Hofland, F Nanne Croles, Arend Jan Gerard Jansen
COVID-19-associated immune thrombocytopenia. British journal of haematology 190 (2) (2020)
Arend Jan Gerard Jansen, Joan van den Bosch, Peter A W Te Boekhorst, Martin R Schipperus, Erik A M Beckers
Results of the prematurely terminated TEMPLE randomized controlled trial in patients with myelodysplastic syndrome: liberal versus restrictive red blood cell transfusion threshold. Transfusion 60 (4) (2020)
Liang Wang, Lei Xu, Hongyuan Hao, Arend Jan Gerard Jansen, Guoqiang Liu, Honglei Li, Xinguang Liu, Yajing Zhao, Jun Peng, Ming Hou
First line treatment of adult patients with primary immune thrombocytopenia: a real-world study. Platelets 31 (1) (2019)
Mingming Qu, Qiang Liu, Hong-Guo Zhao, Jun Peng, Heyu Ni, Ming Hou, Arend Jan Gerard Jansen
Low platelet count as risk factor for infections in patients with primary immune thrombocytopenia: a retrospective evaluation. Annals of hematology 97 (9) (2018)

Arend Jan Gerard Jansen.css-eqlu8i{font-size:small;padding-left:4px;} (A J G Jansen, A J Gerard Jansen)

Publication Activity (10 Years)

Top Topics

Top Venues

Arend Jan Gerard Jansen (A J G Jansen, A J Gerard Jansen)